Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study

Bihui Zhang,Rui He,Ziping Yao,Pengyu Li,Guochen Niu,Ziguang Yan,Yinghua Zou,Xiaoqiang Tong,Min Yang
DOI: https://doi.org/10.1055/s-0044-1786809
2024-05-25
Thrombosis and Haemostasis
Abstract:Background Thromboangiitis obliterans (TAO) is a vascular condition characterized by poor prognosis and an unclear etiology. This study employs Mendelian randomization (MR) to investigate the causal impact of circulating inflammatory proteins on TAO. Methods In this MR analysis, summary statistics from a genome-wide association study meta-analysis of 91 inflammation-related proteins were integrated with independently sourced TAO data from the FinnGen consortium's R10 release. Methods such as inverse variance weighting, MR–Egger regression, weighted median approaches, MR-PRESSO, and multivariable MR (MVMR) analysis were utilized. Results The analysis indicated an association between higher levels of C–C motif chemokine 4 and a reduced risk of TAO, with an odds ratio (OR) of 0.44 (95% confidence interval [CI]: 0.29–0.67; p = 1.4 × 10 −4 ; adjusted p = 0.013). Similarly, glial cell line-derived neurotrophic factor exhibited a suggestively protective effect against TAO (OR: 0.43, 95% CI: 0.22–0.81; p = 0.010; adjusted p = 0.218). Conversely, higher levels of C–C motif chemokine 23 were suggestively linked to an increased risk of TAO (OR: 1.88, 95% CI: 1.21–2.93; p = 0.005; adjusted p = 0.218). The sensitivity analysis and MVMR revealed no evidence of heterogeneity or pleiotropy. Conclusion This study identifies C–C motif chemokine 4 and glial cell line-derived neurotrophic factor as potential protective biomarkers for TAO, whereas C–C motif chemokine 23 emerges as a suggestive risk marker. These findings elucidate potential causal relationships and highlight the significance of these proteins in the pathogenesis and prospective therapeutic strategies for TAO. The datasets analyzed during the current study are available in the EBI GWAS Catalog (accession numbers GCST90274758 to GCST90274848 and GCST90029014), https://www.ebi.ac.uk/gwas/, and the FinnGen repository (finngen_R10_I9_THROMBANG), https://www.finngen.fi/en/access_results. This research has been conducted using published studies and consortia providing publicly available summary statistics. All original studies have been approved by the corresponding ethical review board, and the participants have provided informed consent. In addition, no individual-level data were used in this study. Therefore, no new ethical review board approval was required Conception and design: M.Y. and B.Z. Administrative support: X.T. and Y.Z. Provision of study materials or patients: Z.Y. and G.N. Collection and assembly of data: B.Z., Z.Y., and R.H. Data analysis and interpretation: B.Z., R.H., and Z.Y. Manuscript writing: All authors. Final approval of manuscript: All authors. * These authors equally contributed to this paper and thus shared the co-first authorship. Received: 07 December 2023 Accepted: 05 April 2024 Article published online: 24 May 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
peripheral vascular disease,hematology
What problem does this paper attempt to address?
This paper attempts to explore the causal relationship between circulating inflammatory proteins and thromboangiitis obliterans (TAO) through the Mendelian Randomization (MR) method. Specifically, researchers used the summary statistics of Genome - Wide Association Studies (GWAS) and combined with the data of FinnGen consortium to evaluate the impact of genetic variations of 91 inflammation - related proteins on the risk of TAO. ### Research Background TAO is a vascular disease that mainly affects the small and medium - sized arteries and veins of the extremities, has a poor prognosis and its etiology is unknown. This disease usually occurs in people under 45 years old. Although it has been recognized for more than a century, there is still limited progress in its etiology, pathophysiology and optimal treatment strategies. Recent studies have shown that immune - mediated responses play an important role in the pathogenesis of TAO, but the specific cytokines and their clinical significance have not been fully clarified. ### Research Objectives The purpose of this study is to explore the causal relationship between the levels of circulating inflammatory proteins and the risk of TAO through the Mendelian randomization method, in order to discover new biomarkers and potential treatment targets. ### Main Findings 1. **C - C motif chemokine 4 (CCL4)**: - High levels of CCL4 are associated with a reduced risk of TAO, with an Odds Ratio (OR) of 0.44 (95% confidence interval [CI]: 0.29 - 0.67; p = 1.4×10⁻⁴; adjusted p = 0.013). 2. **Glial cell line - derived neurotrophic factor (GDNF)**: - Higher levels of GDNF also show a protective effect on TAO, with an OR of 0.43 (95% CI: 0.22 - 0.81; p = 0.010; adjusted p = 0.218). 3. **C - C motif chemokine 23 (CCL23)**: - High levels of CCL23 are associated with an increased risk of TAO, with an OR of 1.88 (95% CI: 1.21 - 2.93; p = 0.005; adjusted p = 0.218). ### Sensitivity Analysis - **MR - Egger regression**: No significant horizontal pleiotropy was found (all intercept p > 0.05). - **MR - PRESSO**: No pleiotropic outliers were found (p > 0.05). - **Weighted median method**: The results are consistent, and the estimates are still reliable even if 50% of the information comes from invalid instrumental variables. ### Multivariable Mendelian Randomization Analysis - Even after adjusting for genetically predicted smoking behavior, the protective effects of CCL4 and GDNF and the risk effect of CCL23 remain significant. ### Conclusion This study, through two - sample and multivariable Mendelian randomization analyses, reveals the protective effects of CCL4 and GDNF on TAO and suggests that CCL23 may be associated with an increased risk of TAO. These findings provide a new perspective on potential biomarkers and treatment targets for TAO.